Institut Jules Bordet

Institut Jules Bordet, founded in 1935, is a specialized multidisciplinary hospital located in Brussels, Belgium, dedicated exclusively to oncology. The institution provides comprehensive cancer prevention, diagnostic services, and advanced treatment protocols for various malignancies, including breast and lung cancers, as well as rare tumors. By integrating clinical care with rigorous research and education, the hospital develops predictive tools for cancer progression and maintains a focus on patient-centered outcomes.

Operating with a workforce of 500-1,000 employees at its single facility in Anderlecht, the hospital delivers high-quality medical services. Its technical capabilities include advanced medical imaging technology, minimally invasive surgery, endoscopy, and genetic counseling. The institute actively conducts clinical studies and stem cell research, positioning itself as a leader in European oncology. These services are supported by a robust infrastructure designed to facilitate both patient care and collaborative medical discovery.

The hospital serves a diverse patient base, offering specialized support for smokers and families affected by cancer. Its operational model emphasizes multidisciplinary collaboration among healthcare professionals to ensure precise treatment plans. Meet Institut Jules Bordet's team to learn about their leadership, clinical experts, and the dedicated staff driving their mission. Through its commitment to innovation and patient support, the institute continues to advance the standard of care in the healthcare sector, leveraging decades of experience to address complex oncological challenges.